[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-studies-list:{\"overallStatus\":[\"RECRUITING\",\"AVAILABLE\",\"NOT_YET_RECRUITING\"],\"leadSponsorName\":\"Kurashiki Central Hospital\",\"orderBy\":\"LastUpdateSubmitDate:desc\",\"size\":25,\"offset\":0}":3,"health-study-condition:":35},{"pageToken":4,"total":5,"offset":6,"count":5,"results":7},null,1,0,[8],{"id":9,"slug":4,"hasResults":10,"nctId":11,"briefTitle":12,"officialTitle":13,"acronym":4,"eligibilityCriteria":14,"healthyVolunteers":10,"sex":15,"minAge":16,"maxAge":4,"enrollmentInfo":17,"targetDuration":4,"studyType":20,"phases":4,"briefSummary":21,"conditions":22,"keywords":4,"overallStatus":24,"whyStopped":4,"lastUpdateSubmitDate":25,"lastUpdatePostDateStruct":26,"startDateStruct":28,"completionDateStruct":30,"leadSponsor":32,"locationsCount":5},"100200739",false,"NCT01889459","Japanese CTO PCI Expert Registry","Patient Registry of Percutaneous Coronary Intervention (PCI) for Chronic Total Occlusion (CTO) by Japanese Experts","Inclusion Criteria:\n\nPatients eligible for PCI\n\nPatients who underwent PCI for CTO lesions that contain the following:\n\n1. Thrombolysis in myocardial infarction trial (TIMI) 0\n2. The occlusive period more than 3 months or unknown\n3. The main coronary arteries (segment 1-3, 5-8, 11, 13), branches that have large perfusion area (segment 4PL, 9\u002F10, 12) and graft\n\nExclusion Criteria:\n\nPatients ineligible for PCI judged in clinical practice","ALL","20 Years",{"count":18,"type":19},19000,"ESTIMATED","OBSERVATIONAL","The purpose of this study is to establish a consensus of treatment strategy of percutaneous coronary intervention (PCI) for chronic total occlusion (CTO) through patient registry of PCI for CTO performed by Japanese certified operators.",[23],"Chronic Total Occlusion of Coronary Artery","RECRUITING","2013-07-01",{"date":27,"type":19},"2013-07-02",{"date":29,"type":4},"2013-07",{"date":31,"type":19},"2027-12",{"name":33,"class":34},"Kurashiki Central Hospital","OTHER",""]